FIELD: medicine.
SUBSTANCE: invention refers to a mutant bacterium producing higher levels of intracellular and/or extracellular folate as compared with a wild type which is sensitive to methotrexate, and has growth rate at least 0,1 µ/hour when grown on a medium which contains methotrexate 1.25 mg/l and no folate-dependent metabolites. Also, the invention refers to a composition for foodstuff or food additive enrichment containing said bacterium, and to a method of sampling said bacteria.
EFFECT: invention allows producing high-folate bacteria.
13 cl, 3 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHODS AND COMPOSITIONS FOR IMPROVING PLANT QUALITIES | 2016 |
|
RU2775712C2 |
METHODS AND COMPOSITIONS FOR IMPROVEMENT OF PLANT FEATURES | 2016 |
|
RU2769873C2 |
USING BACTERIA OF NOCARDIOFORM ACTINOMYCETES GROUP FOR PREPARING PHARMACEUTICAL COMPOSITION AND METHOD FOR USING THIS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2543663C2 |
ANTIBACTERIAL COMPOSITION AND METHOD FOR ITS PREPARING | 2000 |
|
RU2241457C2 |
TARGET GENES FOR TARGETED IMPACT ON NITROGEN FIXATION TO IMPROVE PLANT QUALITY | 2018 |
|
RU2805085C2 |
DNA FRAGMENT ENCODING ASPARTOKINASE-III, A METHOD OF L-THREONINE PREPARING | 1993 |
|
RU2113484C1 |
METHOD OF PREPARING AN ATTENUATED STRAIN OF BACTERIUM SALMONELLA | 1988 |
|
RU2114172C1 |
METHOD OF PRODUCING AMINO ACIDS OF ASPARATE FAMILY WITH APPLICATION OF MICROORGANISMS | 2010 |
|
RU2535973C2 |
MUTANT ALPHA-ISOPROPYLMALATE SYNTHASE (IPMS), DNA ENCODING MUTANT IPMS, METHOD OF PREPARING ESCHERICHIA COLI STRAIN, METHOD OF L-LEUCINE PREPARING | 1999 |
|
RU2201454C2 |
STRAINS OF BACTERIUM ESCHERICHIA COLI - PRODUCERS OF L-LEUCINE (VARIANTS) | 1997 |
|
RU2140450C1 |
Authors
Dates
2011-10-20—Published
2006-03-01—Filed